Loading...
XSES
BSL
Market cap1.35bUSD
Jun 18, Last price  
0.95SGD
1D
-0.53%
1Q
-5.50%
Jan 2017
-33.92%
Name

Raffles Medical Group Ltd

Chart & Performance

D1W1MN
XSES:BSL chart
P/E
27.94
P/S
2.31
EPS
0.03
Div Yield, %
2.65%
Shrs. gr., 5y
0.49%
Rev. gr., 5y
7.56%
Revenues
765m
+1.83%
134,248,000168,659,000200,769,000218,610,000239,123,000272,783,000311,633,000340,989,000374,641,000410,535,000473,608,000477,583,000489,135,000522,038,000568,203,000723,791,000766,537,000708,032,000751,564,000765,299,000
Net income
71m
+13.38%
15,713,00035,863,00031,547,00037,882,00045,265,00050,396,00056,849,00084,892,00067,639,00069,291,00070,210,00070,779,00071,056,00060,273,00065,891,00084,171,000143,214,00090,150,00062,243,00070,570,000
CFO
106m
+22.87%
19,663,00040,071,00040,074,00047,209,00049,210,00063,258,00069,545,00071,191,00093,496,00072,816,00078,854,00082,693,00091,528,000111,147,000133,146,000160,112,000196,225,000189,312,00086,254,000105,983,000
Dividend
May 12, 20260.03 SGD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Raffles Medical Group Ltd (RMG), a prominent Singapore-headquartered company, delivers integrated private healthcare services across Singapore, Greater China, Vietnam, Cambodia, and Japan. Its operations are structured into Healthcare Services, Hospital Services, and Investment Holdings segments. The group's flagship institution, Raffles Hospital, functions as a tertiary care facility, offering a broad spectrum of medical services. These include oncology, pediatrics and women's health, traditional Chinese medicine, counseling, dental care, dialysis, diabetes and endocrinology, ENT, ophthalmology, fertility treatments, cardiology, internal medicine, neuroscience, pain management, rehabilitation, orthopedics, dermatological and aesthetic services, general surgery, nuclear medicine, and urology. Beyond the hospital, RMG provides emergency services, family medicine, comprehensive health screening, and a variety of multi-disciplinary specialist clinic services. Additionally, the company engages in the trade of pharmaceutical and nutraceutical products, and diagnostic equipment. It also offers advisory and consultancy services, develops IT solutions, and undertakes research and experimental development in biotechnology, life sciences, and medical science. The company was founded in 1976.
IPO date
Apr 11, 1997
Employees
2,800
Domiciled in
SG
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT